ACTG A5212
Study
Drugs
Subjects will be randomized at entry into one of four arms.
Arm A: palifermin placebo IV bolus daily for 3 days
Arm B: palifermin 20 mcg/kg IV bolus daily for 3 days
Arm C: palifermin 40 mcg/kg IV bolus daily for 3 days
Arm D: palifermin 60 mcg/kg IV bolus daily for 3 days
Eligibility Criteria
HIV
RNA <=200 copies/mL for at least 6 months prior to study entry
CD4+ <200 cells/mm3 at screening
Contact
Beverly
Putnam, RN, ANP (303) 724-0762
Return to HOME